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Parkinson disease is a multifactorial molecular disorder. Miscellaneous regulators 
have been characterized to date and their implication in disease progression is well 
documented. Compromised neuromuscular activity is a serious threat posed by 
malfunctioning of various regulators. The integrity and maintenance of neural architecture 
underpins neural activities. Despite the fact that various breakthroughs have been made, yet 
many proteins are unidentified while some unaddressed. Furthermore, miRNA pathway 
impairment results in subversion of core biological system and draws attention towards 
novel miRNA-based therapeutic strategies. Thus proteins and mitrons work in collaboration 
with various cellular organelles to ensure normal dynamics of neural circuitry. In this review 
we will emphasize the derailed activities of proteins at molecular level that might help in 
getting a step closer to personalized medicine. 
 
 
Parkinson’s disease is a neuro-
degenerative disorder. There is an excessive 
loss of dopaminergic neurons. Recent 
research is on the brink of achieving a new 
level of understanding in terms of 
Parkinson’s disease. Consistent milestones 
have been set in the comprehensions of this 
disorder. Neuronal death is the main 
mechanism that underlies the subversion of 
core biological system driving neuronal 
activities. In accordance with this 
assumption, delineation of the key players 
extensively implicated is necessary. A 
detailed mechanistic insight of the 
mitochondria and a better knowledge of the 
modulations engaged in apoptosis are 
competent for attention to bridge the existing 
gaps. In this review we will bring to 
limelight, the key proteins involved in 
disease progression, signal transduction 
cascades which drive neurodegeneration and 
new patterns in therapeutics with emphasis 
on miRNA. 
 
Parkinson’s disease 
Parkinson’s disease (PD), is 
statistically positioned to be the second most 
prevalent neurodegenerative disorder after 
Alzheimer’s disease (AD) (Weintraub et al, 
2008). James Parkinson being the first to 
explicate PD in 1817 in a publication “An 
Essay on the Shaking Palsy” (Parkinson, 
1817). It is a slowly progressive neuro-
degenerative molecular disorder with 
selective loss of dopaminergic neurons. 
Dopamine is a neurotransmitter, which is 
released into the synaptic cleft, in response to 
presynaptic action potential. It is noteworthy 
that dopamine controls voluntary 
movements, sleep, mood, working memory, 
learning etc. The common age of onset is in 
the early 60s, but up to 10% of affected are 45 
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years or younger. Environmental and genetic 
factors are instrumental in the pathogenesis 
of PD but familial forms of PD are rare, just 5-
10% (Weintraub et al., 2008; Lesage & Brice, 
2009). 
  
 A typical feature seen in post-mortem 
brains of patients with PD is the presence of 
proteinaceous intracytoplasmic inclusions 
called Lewy bodies (LBs) (Lesage & Brice, 
2009). The LBs are made up of numerous 
different proteins and their main component 
is α-synuclein and mitochondria 
(Wakabayashi et al., 2007). Many genes are 
associated with Parkinsonism. PINK1, Parkin, 
DJ-1 and HtrA2 are four of them (Lesage & 
Brice, 2009). PINK1, Park-6 is a mitochondrial 
kinase. This is responsible for early onset of 
PD (autosomal recessive and sporadic). 
Parkin is a ubiquitin E3 ligase also called 
Park-2 basis of EOPD (AR). A mitochondrial 
chaperon, DJ-1 also known as Park-7 also 
causes EOPD (AR) and Omi/HtrA2 a 
mitochondrial serine protease also called 
Park-13.  
 
Structure of Mitochondria 
Mitochondria play a vital role to maintain the 
integrity of neurons. Mitochondria have five 
sub compartments: outer mitochondrial 
membrane (OMM), intermembrane space 
(IMS), inner mitochondrial membrane (IMM), 
cristae and matrix.  Cristae, are invaginations 
of the IMM, which increases the surface area 
of the IMM, enhancing its ability to produce 
ATP and separates proapoptotic proteins 
from matrix in the IMS (Zhang et al., 2008). 
The mtDNA is found in the matrix, the space 
enclosed by the IMM. mtDNA consists of a 
circular 16kb DNA molecule that encodes 37 
genes.  Several hundred copies of mtDNA 
can be found in one mitochondrion. I-IV 
complexes of the electron transport chain 
(ETC) and complex V, the ATPsynthase, 
which conducts ATP production, are 
embedded in the IMM. Mitochondria are 
ATP producers, particularly in neurons they 
are also responsible for Calcium signaling, 
protein degradation and apoptosis. Abnormal 
protein aggregation causes dysfunctioning, 
increased oxidative stress. This leads to the 
pathogenesis of PD (Zick et al., 2009). 
 
Structure of PINK1 protein 
In the human genome PINK1 also called 
PARK6.Located on the 1p36 locus. PINK1 
gene has eight exons and encodes protein 
consist of 581 amino acids. N-terminal 
sequence, the Mitochondrial targeting 
sequence (MTS) proceeded by a 
transmembrane domain (TM), a Serine / 
threonine kinase domain being highly 
conserved (which resembles to the Ca2+/ 
calmodulin family of kinases) and at C-
terminal a regulatory domain (Mills et al., 
2008; Silvestri et al., 2005). Length of MTS is 1 
- 77 amino acids. TM contains 94 – 110 amino 
acids. KD the highly conserved domain 
contains 156 – 511 amino acids and regulatory 
domain consists of 511 – 581 amino acids. The 
full-length of PINK1 protein is of ~63kDa. 
This is further proteolytically cleaved into 
~55kDa by an unknown protease. In the 
mitochondria isolated from brain of rat, 
PINK1 protein is localized in both IMM and 
OMM (Gandhi et al., 2006). Another study 
affirmed PINK1 in IMM and IMS (Gandhi et 
al., 2006; Pridgeon et al., 2007). 
 
 
Fig 1: Structure of PINK1 
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PINK1 protects against oxidative-stress-
induced cell death by phosphorylating 
mitochondrial TRAP1  
A mutation in the PINK1 gene, which 
encodes a Serine/Threonine kinase leads to 
autosomal recessive form of Parkinson 
disease (PD) (Gegg et al., 2009). Kinase 
domain of Pink1 is involved in the 
autophosphorylation and phosphorylation of 
mitochondrial substrate TRAP1 (tumor 
necrosis factor receptor–associated protein 1) 
respectively. Both PINK1 and TRAP1 are 
predicted to possess a mitochondria targeting 
signal at their N-terminal and both are 
localized in the mitochondrial intermembrane 
(Silvestri et al., 2005).  Fractionation studies on 
mitochondria show that PINK1 and TRAP1 
both are found in the mitochondrial inner 
membrane and intermembrane space 
fractions (Gegg et al., 2009).             
                                                                                 
 
Figure 2: PINK1 protects cell from Oxidative Stress induced Apoptosis. 
PINK1 mutations such as G309D, 
L347P, and W437X lead to impaired cell 
survival and its ability to phosphorylate 
TRAP1 (Pridgeon et al., 2007; Kroemer and 
Blomgren, 2007).  PINK1 kinase activity has 
not radically been affected by PCI2 cells with 
K219A mutation however the ability of 
PINK1 to phospohorylate TRAP1 is 
dramatically decreased during D362A, 
D384A and KDD triple mutations (Pridgeon 
et al., 2007). TRAP1 is a mitochondrial heat 
shock protein 75 (Hsp75) and is chaperone in 
nature. TRAP1 and ROS act in opposition to 
each other i.e. if TRAP1 is silenced via RNA 
interference a significant increase in the 
accumulated ROS is observed (Hua et al., 
2007). Oxidative stress promptly resulted in 
an enhanced phosphorylation of TRAP1. The 
activity was remarkably increased in PINK1 
overexpressed cell lines and there was a 
dramatic decline in the activity in PINK1 
incompetent cells. This undercores the fact 
that TRAP1 is a direct substrate of PINK1.    
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    Figure 2.1: ROS induced dopaminergic neurons death due to mutated PINK1.   
 
Phosphorylated TRAP1 then blocks 
the generation of mitochondrial ROS. This 
further blocks the opening of mitochondrial 
permeability transition pore (MPTP). It 
causes the inhibition of release of cytochrome 
c, smac and endonuclease G from 
mitochondria into cytosol (Xiang et al., 2010). 
Phosphorylation of TRAP1 is significantly 
increased due to oxidative stress induced by 
H2O2. Over expression of wild-type PINK1 3-
foldd increases the basal level of TRAP1 
phosphorylation. PC12 Cells with wild-type 
PINK1 were much more resistant to H2O2-
induced cell death as compared to PINK1 
mutant cells (Pridgeon et al., 2007). Pink1 
indirectly protects dopaminergic neurons of 
substantia nigra from apoptosis induced cell 
death and promotes cell survival, thus it has a 
neuroprotective role in human brain 
(Kroemer and Blomgren, 2007; Pridgeon et al., 
2007). This evidence suggests that Trap1 and 
PINK1 are part of antiapoptotic signaling 
cascade (Tatsuta and Langer, 2008). TRAP1 
chaperones the retinoblastoma protein. it 
regulates the cell-cycle. It is up regulated by 
the oncogene c-Myc and down-regulated in 
HIV-1–infected cells. The HSP90 inhibitor, 
geldanamycin causes suppression of TRAP1 
(Kroemer and Blomgren, 2007). 
 
Role of PINK1 in mitochondrial respiration 
and protein degradation   
PINK1 (PTEN induced putative 
kinase1); PTEN is phospho & tensin 
homology. PINK1 gene located on 
chromosome # 1p35-36 and exists in form of 
dimer. A significant proportion of PINK1 has 
been localized to both the inner and outer 
mitochondrial membranes (Charleen, 2010; 
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Silvestri et al., 2005). PINK1 encodes a 581-
amino-acid protein with a predicted N-
terminal mitochondrial targeting sequence 
and a conserved serine/threonine kinase 
domain (Charleen, 2010). Stress signaling, 
which is induced by ROS (reactive oxygen 
species) and artificially by hydrogen peroxide 
causes the transcription of PINK1 gene (ROS 
produces as a result of oxidative reactions in 
the mitochondria, for energy production). 
Then this protein causes the phosphorylation 
of TRAP1, which is its substrate (TNF 
receptor-associated protein 1) inside the 
mitochondria. To promote the cell survival 
PINK1 causes the phosphorylation of the 
mitochondrial molecular chaperone TRAP1. 
This infers the normal activity of PINK1 
being the protection against cell death 
induced by oxidative stress. In PC12 cells due 
to H2O2-induced oxidative stress, over 
expression of wild-type PINK1 causes a 
significant reduction in the release of 
cytochrome c. The inhibitory effect of PINK1 
on cytochrome c release is totally abolished 
by the catalytically inactive D362A mutation 
and the triple KDD mutations. The deletion 
in PINK1 considerably increases oxidative-
stress-induced release of cytochrome c from 
mitochondria to the cytosol in PC 12 cells, 
which suggest that kinase activity of PINK1 is 
critically involved in the regulation of 
mitochondrial apoptotic pathway. PINK1/ 
Parkin pathway has a regulatory role in the 
mitochondrial morphology Parkin is a 
cytosolic substrate of PINK1. PINK1-deficient 
cells are, unable to recruit Parkin followed by 
an impairment of mitochondrial functions 
(McBride et al., 2008; Poole et al., 2008). The 
mitochondrial dysfunction caused by loosing 
PINK1 is evidently restored by Parkin, it is 
uncertain whether a direct molecular 
communication between PINK1 and Parkin is 
necessary for efficient removal of injured 
mitochondria. Pink1 & Parkin, both work in a 
common pathway to maintain the integrity of 
mitochondria & cell survival (Clark et al., 
2006; Yang et al., 2006). The PD-linked PINK1 
G309D, L347P mutations impair the PINK1 
activity of promoting TRAP1 phosphory-
lation and cell survival, but W437X mutations 
to some extent. Due to harsh mitochondrial 
injury, PINK1 due to its interactions with 
Parkin facilitates aggregation and clearance of 
depolarized mitochondria. PINK1 protein is 
modified by, post-translational modification 
and localized into mitochondria. Excess 
expression of full-length PINK1 is 
compulsory for mitochondrial Parkin 
recruitment (Charleen, 2010). Full length 
PINK1 pre-protein (~63 kDa) is cleaved to a 
‘mature’ form (54 kDa) by an unknown 
protease. PINK1 mRNA is expressed in 
human tissues, with highest expression in 
muscles. (Kaczmar et al., 2008; Gandhi et al., 
2006; Muqit et al., 2006). In PD mostly 
mutations of PINK1 are found within the 
ATP binding site of kinase domain. 
Mutations in N-terminus & C-terminus of 
protein are also important for optimal activity 
of kinase domain. Mutated PTEN (phospho 
and tensin homology) induced putative 
kinase 1 (PINK1) gene causes an autosomal 
recessive form of Parkinson disease (PD), a 
neurodegenerative disease of dopamenergic 
neurons of mid brain due to decrease in 
mRNA of PINK1 in them which leads to the 
decrease phosphorylation of TRAP1. PINK1 
is one of the genes out of 7 mitochondrial 
genes encoding complex I subunits of ETC. In 
idiopathic PD abundance of mutations are 
present in a very narrow region of the 
mitochondrial complex I gene, ND5 
substantia nigra of PD brains (Gegg et al., 
2009; Park et al., 2006). PINK1 is an essential 
mitochondrial quality control regulator, 
which promotes the maintenance of 
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mitochondrial respiration. The mitochondrial 
electron transport chain (ETC) impairment 
and an increased deletion rate of 
mitochondrial DNA (mtDNA), which 
encompasses some of the  ETC sub-units due 
to over production of ROS in case of genetic 
ablations of PINK1. PINK1 is involved with 
the respiratory complex 1 (NADH : 
ubiquinone oxidoreductase) of ETC so 
because of inhibition of complex1 by the 
neurotoxin, MPTP (1-methyl-4-phenyl tetra 
hydropyridine), produces parkinsonism in 
humans. Suggesting that one of the main 
causes of neuron loss and motor impairment 
in PD is toxin-induced mitochondrial stress in 
dopaminergic neurons but the actual 
mechanism by which PINK1 mutations lead 
to neurodegeneration is unknown (Charleen, 
2010; Gegg et al., 2009; Piccoli et al., 2008). 
 
 
Figure 3.0: Impaired Mitochondrial Respiration due to mutated PINK1. 
 
MPTP is transformed in to a derivative, 
1-methyl-4-phenylpyridinium (MPP+) and 
this derivative inhibits complex I of the 
mitochondrial ETC. Epidemiologic studies 
also propose mitochondria-toxic pesticides 
may increase PD risk. Rotenone is also 
complex I inhibitor (Swerdlow, 2009). Pham 
et al., 2000 states that an increased production 
of mitochondrial reactive oxygen 
intermediates (ROI) due to the impaired 
activity of respiratory chain ultimately 
proceeds with physiological processes 
namely apoptosis, being a part of both cases 
i.e., normally the aging process and as well 
during the abnormal mitochondrial 
pathogenesis. Flow cytometry procedures 
revealed that there is a marked relationship 
between the generation of mitochondrial ROI 
and disordered functions of respiratory chain 
complexes. The genetics of mitochondria also 
gave a helping hand to the investigators for 
the identification of several rare disorders as 
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likely arising from mutation of mitochondrial 
DNA (mtDNA). This indicates that deficiency 
of complex 1 in electron transport chain 
defects due to mutated PINK1 leads to 
degeneration of dopaminergic neurons in the 
central nervous system. In an experimental 
PINK1 compromised model from a human 
dopaminergic neuroblastoma cell line with 
shRNA leads to decreased mitochondria 
membrane potential as compared to wild-
type. This also causes decreased 
mitochondrial respiration, because provision 
of substrates for mitochondrial complexes I 
and II partially declines and shortfalls. The 
lack of substrate supply also augmented the 
plenty of the oxidized forms of NADH and 
FAD2+ in mitochondria lacking functional 
PINK1 (Ray, 2009). The F(1)-ATP synthase 
become reverse  When mitochondrial 
respiration decreases and start using ATP, 
helping to retain the mitochondrial 
membrane potential. The density of 
mitochondrial cristae is increased by IF (1) 
over expression and decreased by IF (1) 
repression; and IF (1) over expression 
increases the formation of ATP syntheses 
complexes and increases F (1) F(o)-ATP 
synthase activity. (Campanella et al., 2008). 
Several studies on the loss of Pink1 or parkin 
in Drosophila show significant mitochondrial 
swelling (Clark et al., 2006; Park et al., 2006). 
In a mice with germline deletions of the 
PINK1-/- gene leads to impairment of 
mitochondrial functions. At 3-4 and 24 
months under quantitative electron 
microscopic study of PINK1-/- mice, shows 
that, there are no changes in the 
ultrastructure or the total number of 
mitochondria but number of larger 
mitochondria is selectively increased as well 
as impaired mitochondrial respiration only in 
the dopamenergic neurons but after two 
years later also in the cerebral cortex . This 
indicates that aging can aggravate 
mitochondrial dysfunction in these mice and 
mitochondrial respiration defects can be 
induced in the cerebral cortex of PINK1-/- 
mice by cellular stress (Gautier et al., 2008). 
The phenotypes of PINK1 or Parkin mutant 
Drosophila are very similar, PINK1 is not 
capable to rescue the faults caused by the lack 
of parkin but the over expression of parkin 
rescues the mitochondrial pathology induced 
by the knocked out Pink1. Mammalian 
PINK1-lacking cells confirm fragmented and 
truncated mitochondria. The molecular 
interaction between Parkin and PINK1 is 
conserved in mammalian cells (Lutz et al., 
2009; Exner et al., 2007). As mutant PINK1 
leads to impaired proteasome function & 
increase in alpha-synuclein aggregation, 
which leads to the toxicity in neurons and 
mitochondrial dysfunction plays an 
important role in initiation of apoptotic 
(Budd et al., 2000; Radke et al., 2008). 
Protein aggregation due to mitochondrial 
dysfunctioning plays an important role in the 
pathogenesis of PD. α-synuclein is a fibrillar 
aggregation of protein that is a main 
constituent of Lewy bodies and is supposed 
to contribute to PD due to their toxic effects. 
Although α-synuclein is mostly cytosolic 
protein but in numerous transgenic mouse 
models mitochondrial abnormalities were 
observed that either lacks or over express 
wild-type or mutant α-synuclein (Poon et al., 
2005; Martin et al,2006).  These studies 
indicate that in the mitochondria, α-synuclein 
has a physiological role because α-synuclein 
interacts with mitochondrial proteins of 
dopamenergic neurons (Ellis et al., 2005). In a 
Drosophila loss of PINK1 causes an increase 
of α-synuclein aggregation in the 
mitochondria but due to over expression of 
PINK1 α-synuclein, accumulation is 
suppressed (Castro et al., 2010; Liu et al., 
2009). Moreover, in case of the oxidative 
mitochondrial stress and to keep away the 
toxic aggregation of α-synuclein via 
oxidation, the chaperone DJ-1 has been 
admired to undergo relocation (Hayashi et al., 
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2009; Junn et al., 2009; Shendelman et al., 
2004). Omi/HtrA2 and DJ-1 along with 
PINK1 offer protective functions within 
mitochondria to maintain the integrity of 
neuronal cells (Plun et al., 2007; Strauss et al., 
2005). PINK1, Parkin, and DJ-1 formed a 
complex known as PPD complex, which 
promotes the degradation of unfolded 
mitochondrial proteins (Xiong et al., 2009). It 
has been evidently suggested that PINK1 
deficiency results in diminished long term 
viability in human neurons, whose death 
relies in the apoptosis pathway of 
mitochondria. (Kaczmar et al., 2008; Unoki et 
al., 2001). So PINK1 also helps in the 
mitochondrial respiration and ATP 
production as well as in protein degradation. 
 
 
Figure 3.1: Mutated PINK1 is associated with the pathogenesis of Parkinson’s Disease 
 
Contribution of PINK1 in Calcium 
Signaling 
PINK1 plays a significant role in the Calcium 
Signaling. Mitochondrial Ca2+ accumulation 
is a tightly controlled process. Deregulation 
of Mitochondrial Ca2+ induces death of 
neurons. PINK1 physiologically regulates the 
calcium efflux from the mitochondria 
through the ATP dependent mitochondrial 
Na+/Ca2+ exchanger. PINK1 deficiency 
causes to malfunction of a Na+/Ca2+ 
exchanger due to lack of ATP, thus avoiding 
the proper calcium efflux from the 
mitochondria induces mitochondrial 
accumulation of free calcium and 
mitochondrial calcium overload. (Abramov et 
al., 2007; Ray, 2007; Gandhi et al., 2009). 
Calcium overload causes the stimulation of 
reactive oxygen species (ROS) production. 
Then ROS inhibits the glucose transporter 
which causes the decrease delivery of 
substrate to the Complex 1 of the ETC. This 
leads to impaired respiration in the 
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mitochondria. Increased ROS production also 
causes decreased mitochondrial membrane 
potential and ATP production. This reduced 
mitochondrial membrane potential induces 
the MPTP opening at lower stimulus due to 
decreased threshold require by the cells to 
open MPTP. Cytochrome c releases through 
the MPTP into the cytosol causes apoptosis of 
the cell. Mitochondrial membrane potential 
(∆ψm) is a pointer of mitochondrial state. 
Mitochondrial Ca2+  in neuronal cells death 
highlighting the role of Ca2+ in the 
pathogenesis of Parkinson's diseases  
(Szabadkai et al., 2006 ; Gandhi et al., 2009; 
Ray, 2009). A neuronal cell model of PD 
analyzed for cell survival, mitochondrial 
activity and calcium flux. These cells infected 
with virally-delivered Pink1. Under confocal 
and electron microscopy mutant (W437X) 
shows alterations in mitochondrial function 
but not the wildtype Pink1. This effect is 
linked with increased intracellular calcium 
levels. In a Parkinson’s disease model of 
neuron cell a dysfunction is induced in 
mitochondria via mutant PINK1 (Mattson, 
2007; Gandhi, 2009). In the PINK1 KD 
neuroblastoma cells the significantly reduced 
oxygen consumption is observed because lack 
of substrates for complex I in these cells, 
inhibits respiration. (Gandhi et al., 2009; 
Szabadkai et al., 2006). As a decreased 
gulucose uptake in the neurons of human and 
mouse is evidently associated with deficient 
PINK1. In these cells it is also observed that 
the rate of basal mitochondrial ROS (mROS) 
production was also significantly higher in 
PINK1 KD cells (Scheele et al., 2007; 
Anantharam et al., 2007). In another 
experiment, the PINK1 KD neurons has high 
mitochondrial Ca2+ level followed by a 
stepwise mitochondrial depolarization. 
Which is associated with lowering of ∆ψm.                                                                                                                   
This mitochondrial depolarization was 
prohibited by the administration of 
cyclosporin A (CsA). Cyclosporin A basically 
inhibits mPTP but pyruvate and methyl 
succinate which are the substrates of 
respiratory chain are not able to avoid the 
mitochondrial depolarization induced by 
calcium in PINK1 KD cells (Mattson, 
2007).This indicates that reduced substrate 
delivery causes the impairment of respiration 
and reduced ∆ψm in cells that lack PINK1 
(Scheele et al., 2007 ; Ray, 2009, b; Gandhi et 
al., 2009). The PINK1 also interacts with the 
calcium sensing molecule NCS-1. This 
regulates the neurotransmitter release. Thus 
mitochondrial calcium functions as a 
neuronal pro-survival factor (Nakamura et al., 
2006). PINK1 also has an additional indirect 
role in calcium signalling in zebrafish (Petko 
et al., 2009).           
Parkin / E3 ligase and PINK1’S Relation 
Parkin plays a very important 
neuroprotective role along with Pink1 as well 
as with DJ-1 & alpha synuclein. Parkin is the 
gene product of PARK2 & it is also called E3 
ligase of ubiquitin proteasome pathway. 
Which is involved in the degradation of 
neurotoxic proteins   (Vercammen  et al., 
2006). Chung and colleagues state that the 
direct phosphorylation of Parkin by PINk1 on 
Thr175, the kinase domain of which  faces the 
cytosol is responsible for the recruitment of 
Parkin. Parkin has an N-terminal ubiquitin 
like domain & it is a component of multiple 
proteins in of ubiquitin proteasome system 
(UPS) (Ayako et al., 2005). Most of the 
neurodegenerative diseases are due to 
degeneration of specific neuronal population. 
Due to misfolding, aggregation & then their 
neurotoxic effects on neurons. (Yang et al., 
2006). Mutations of PINK1, Parkin & DJ-1 
leads to autosomal recessive form of 
Parkinson’s disease (PD). (Xiong et al., 2009). 
As mutations of these genes cause 
accumulation of Parkin’s substrate proteins 
which leads to toxicity in the neuro 
(Vercammen et al., 2006). Parkin has both 
degradative & nondegradative roles. As an 
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E3 ubiquitin ligase, Parkin causes 
polyubiquitnation of numerous proteins 
(misfold /denatured, short lived or 
regulatory) for their degradation by ubiquitin 
proteasome system (UPS). A signal ubiquitin 
molecule attached with these proteins before 
their degradation by UPS. Many studies 
suggest that Pink1 and Parkin, both work in a 
common pathway to maintain the integrity of 
mitochondria and cell survival. (Clark et al., 
2006; Yang et al., 2006). Park et al., 2006 stated 
that mutants of pink1 and Parkin share 
marked phenotypic similarities. 
Mitochondrial dysfunctioning also 
contributes in the etiology of Parkinson’s 
disease. In Hela cells the down regulation of 
Pink1 due to RNA interference causes many 
abnormalities in the mitochondria of the cell 
like altered mitochondrial membrane 
potential and abnormal mitochondria’s 
morphology which leads to cellular stress & 
pathological phenotype (Exner et al., 2007). 
Similarly drosophila in which Pink1 
depletion leads to dysfunctioning of 
mitochondria, energy depletion, degradation 
of muscles & dopaminergic neurons of 
substantia nigra is rescued by over expression 
of Parkin. Here this thing is important that 
Pink1 is unable to rescue or overcome the 
abnormalities in the drosophila, in which 
Parkin is knocked out. (Clark et al., 2006 ; 
Park et al., 2006). Parkin suppresses the death 
of  dopaminergic neurons induced by 
oxidative stress as well as due to unfolded 
protein stress. (Yang et al., 2006; Lo Bianco et 
al., 2004). Pink1 along with Parkin & DJ-1 
form a complex known as PPD complex. This 
promotes polyubiquitnation & then 
degradation of Parkin’s substrates. (Xiong et 
al., 2009). Parkin-associated endothelin-like 
receptor (Pact-R), alpha synuclein & alpha 
synuclein binding protein (synphilin1 
proteins) are substrate of Parkin. (Yang et al., 
2003; Lo Bianco et al., 2004). These substrate 
proteins get accumulated in case of genetic 
ablations of Pink1 because Parkin mediated 
degradation of misfolded proteins is 
enhanced by Pink1. Genetic ablations in the 
gene of alpha synuclein are linked to the early 
onset of familial form of Parkinson’s disease. 
As Parkinson’s disease associated alpha 
synuclein mutant protein aggregations are 
major component of cytoplasmic inclusions 
known as Lewy’s bodies in dopaminergic 
neurons of substantia nigra. (Xiong et al., 
2009). Along with Pink1 protein Parkin acts 
as a central player in the pathogenesis of  
Parkinson’s disease as it suppresses the 
neurotoxicity due to accumulation of Putative 
G protein coupled transmembrane receptor 
(Pact-R) and alpha synuclein. Parkin 
degrades proteins with aberrant 
conformation and is associated with 
autosomal recessive Juverile Parkinsonism 
(AR-JP) (Yang et al., 2003; Rankin et al., 2005). 
In PARK2 gene recessively inherited 
duplications / deletions & point mutations 
are the most common cause of early onset of 
Parkinsonism (Myhre et al., 2008). Rankin et 
al., 2005 cloned & expressed human Parkin in 
E-coli and examined Parkin mediated 
ubiquitnation in an ubiquitnation invitro 
assay. They observed that E3 ligase activity is 
an intrinsic function of Parkin protein and 
does not require post translation 
modifications or associaton with cellular 
protein other than an E3 ligase. 
 
Activation of NF-KB signaling by PINK1 & 
Parkin 
One pathway of activation of NF-KB through 
IKK complex is called “classical,” or 
canonical, pathway. Other pathway of NF-KB 
is called alternative,” or noncanonical, 
pathway (Zarnegar et al., 2007).  
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NF-KB is a key player to maintain the 
integrity of neurons. As NF-KB is present 
throughout the nervous system. NF-KB is a 
transcription factor which regulates many 
physiological functions and also involved in 
the pathogenesis of disease. PINK1 activates 
and enhances the E3 ligase activity of Parkin 
by phosphorylating it directly (Sha et al., 
2009). This further causes the ubiquitnation of 
NEMO and TRAF2 (Chen, 2005). Activation 
of NF-KB in neurons promotes their survival 
and activation of NF-KB in glial and immune 
mediated cells leads to pathological 
inflammation. Physiologically Parkin causes 
the activation of signaling cascade for 
neuroprotection. This neuroprotection is 
abolished when genetic ablations of pink1 or 
Parkin occurs because these mutant genes are 
unable to activate NF-KB and leads to the 
pathogenesis of Parkinson’s disease, Epilepsy 
and AD (Sha et al., 2009).Activation of NF-KB 
causes the transcription of those genes which 
supports pro-survival activities in neurons. 
These are anti apoptotic proteins such as Bcl-
2. This shows that Parkin has cytoprotective 
role. 
  
 
 
Figure.4.0: Activation of NFKB signaling by PINK1 
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Figure.4.1: Neuronal survival by activation of antiapoptotic Bcl-2 through PINK1 
 
Recent studies indicated that Parkin 
has cytoprotective function in cell cultures 
and in animal models by activation of NF-KB 
because mutated Parkin in HEK293T cells is 
unable to trigger NF-KB pathway (Henn et al., 
2007).  NF-KB dependent genes transcription 
is stimulated by Parkin in HEK293T cells. 
These genes further sustain the neuronal 
survival. In SH-SY5Y cells, activation of NF-
KB pathway is essential for protection of 
neurons from apoptosis. It is observed that in 
HEK293T cells Parkin forms a complex with 
IKK and TRAF 2. Analysis show that Parkin 
causes activation of NF-KB pathway which is 
essential for the neuronal survival.IKK 
complex consists of two subunits. IKK 
regulatory subunit also called NEMO (NF-B 
essential modifier) and a catalytic subunit 
IKKB (Sha et al., 2009).The NF-B pathway is a 
paradigm for ubiquitylation mediated 
dependent degradation. Ubiquitnation in the 
NF-KB pathway includes targeting of IB for 
degradation by binding of Ubiquitin moiety 
(Chen, 2005; Krappmann and Scheidereit, 
2005). Naoi et al., 2009 stated that they 
evaluate the cytoprotective activity of Parkin 
by two stressors relevant to, rotenone induces 
inhibition of complex I of the electron 
transport chain and glutamate induces 
excitotoxicity. Both stressors drastically 
increased the quantity of Parkin specific 
mRNA in cultured neuroblastoma cells as 
well as primary neurons, consequential in an 
increased expression of Parkin protein. 
Pathogenic muated parkins do not exhibit a 
complete loss of function when over 
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expressed in cultured cells. However a 
blockage of the NF-B pathway leads to a loss 
of protective activity of parkin in 
dopaminergic neurons, this proceeds via the 
modulation of NF-KB pathway; Parkin 
initiates a neuroprotective plan under 
lowered-level and moderate stress. The 
promoter region of parkin associates 
numerous stress response elements. The 
experimental model predicts that the surplus 
expression of parkin remains sufficient to 
activate NF-B cascade and the parkin’s 
phosphorylation status is very important for 
its activity (Yamamoto et al., 2005). Under the 
moderate stress activated PINK1 causes the 
phosphorylation of Parkin in the cytosol of 
dopaminergic neurons and then activated 
Parkin causes the lys-63 linked ubiquitnation 
of NEMO and TRAF2 in the form of 
polyubiquitin chain by adding Ubiquitin 
moiety (Sha et al., 2009). These polyubiquitin 
chains contain lys 63 / Gly 76 isopeptide 
linkages. This isopeptide linkage is between 
the glysine 76 amino acid at the C-terminal of 
Ubiquitin moiety and Lysine 63 amino acid of 
substrate protein (Moore, 2006). This further 
leads to the phosphorylation and activation 
of catalytic subunit of IKK complex that is 
IKKB. This activated subunit causes 
inhibition of IKB by its phosphorylation and 
Lys48-linked polyubiquitylation. In its 
inactivated version NF-KB binds with IKB 
but when IKB is inhibited by IKK complex 
NF-KB gets free. The polyubiquitylated IKB 
leads to proteasomal degradation and 
activated NF-KB translocates in the nucleus 
for the transcription of antiapoptotic genes 
for survival of dopaminergic neurons. 
 
PINK1, Parkin and JNK pathway: Two’s a 
company, Three’s a crowd 
JNK pathway is also controlled by PINK1 and 
Parkin in dopaminergic neurons. Under 
oxidative stress PINK1 causes 
phosphorylation of Parkin. This activated 
Parkin causes the activation of Akt by its 
phosphorylation. This activated Akt blocks 
the JNK pathway. NF-kappaB promotes 
survival, whereas JNK enhances stress 
induced apoptosis in dopaminergic neurons 
of substantia nigra and leads to pathogenesis 
of Parkinson’s disease (Chang et al., 2006). 
Administration of neurotoxin 1-methyl-4-
phenyl-1,2,3,6-tetrahydropyridine (MPTP) in 
SH-SY5Y human neuroblastoma cells in vitro 
and in mice in vivo causes activation of JNK 
pathway by phosphorylation JNK. This 
causes the activation of caspases which leads 
to apoptosis of these cells. The dopaminergic 
neurons in the substantia nigra of brain are 
selectively lost due to the apoptosis induced 
by the neurotoxin MPTP. Treatment of mice 
with SP600125 an inhibitor of JNK pathway 
lead to a reduction in phosphorylation of 
JNK. This decreased the apoptosis of 
dopaminergic neurons and restored the 
dopamine level in the MPTP induced 
Parkinson’s disease (Wang et al., 2004; Xia et 
al., 2001). This indicates that inhibitor of JNK 
pathway protects dopaminergic neurons 
from apoptosis induced by neurotoxin (Peng 
et al., 2004). Mutant Parkin in the Drosophila 
leads to decreased levels of dopamine in their 
brain because of highly activated JNK 
pathway in Parkin mutant flies. These results 
suggest that Parkin inhibits the JNK signaling 
pathway and loss of cytoprotective functions 
of Parkin, in Parkin mutant flies, there is an 
up regulation of JNK pathway. This further 
leads to autosomal recessive juvenile 
Parkinsonism (Cha et al., 2005). Cha et al., 
2005 also stated that Parkin inhibits JNK 
pathway in the Drosophila and human 
neuroblastoma cells. This indicates that 
Parkin down-regulates the proapoptotic JNK 
pathway. 
 
Role of PINK1 in PI3k/Akt pathway 
As a result of oxidative stress PINK1 causes 
activation of Parkin. This activated Parkin 
causes phosphorylation of Akt which causes 
activations of many other molecules by 
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phosphorylating them such as GSK3, FoxoA2 
to hinder the apoptosis (Rise et al., 2006). 
PI3K/Akt are also important targets of 
Parkin. Activation of PI3K/Akt pathway 
protects the dopaminergic neurons of 
substantia nigra from the apoptosis (Yuan J. 
and Yankner, 2000). Activated parkin blocks 
the endocytosis of neurotropin receptor 
which is present on the cell membrane. 
Neurotropin receptor further causes the 
activation of PI3K. This PI3K acts on its 
substrate, phosphatidylinositol-4,5-
bisphosphate. This pathway leads to the 
phosphorylation plasma membrane 
phosphatidylinositol-4,5-bisphosphate in to 
phosphatidylinositol- 3,4,5-P3   by  PI3K 
(Vanhaesebroeck, 2001). This conversion 
plays a very important neuroprotective role 
because it triggers the activations of Akt. 
Kittappa et al., 2007 stated that Akt protects 
dopaminergic neurons of a mouse from 
neurotoxin 6-hydroxy-dopamine induced 
apoptosis. As it acts as antioxidative stress 
factor (Mei et al 2009). In another experiment 
it is observed that amount of activated Akt 
decreases in a Parkin mutant Drosophila and 
concludes that Parkin plays a very important 
role in the phosphorylation of Akt in 
neuronal cells (Rise et al., 2006). Experiments 
with pharmacological inhibitors of Akt also 
demonstrated that Akt mediates PI3-K-
dependent survival of neurons (Dudek et at, 
2007). FoxoA2 is one of the substrate of Akt 
and an important transcription factor. Loss of 
FoxoA2 also causes selective loss of neurons. 
In a mice having only one copy of the gene 
for FoxoA2 leads to decrease neuronal 
survival (Kittappa et al., 2007). These 
evidence shows that PI3K/Akt pathway 
plays a very important role in protection and 
survival of dopaminergic neurons against 
oxidative stress induced apoptosis with the 
help of activated PINK1 and Parkin. 
Phosphorylated Akt also blocks the 
polymerized Bax, present on the 
mitochondrial membrane to prevent the 
release of cytochrome c, smac in to cytosol 
from mitochondria. 
 
Figure 5: Activation of PI3k / Akt signaling. 
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Figure 6: Ubiquitin independent degradation of mitochondrial proteins by HtrA2. 
 
Mitochondrial Protease/HtrA2 and PINK1’s 
Job  
High temperature requirement A2 (HtrA2) 
also called Omi, is one member of HtrA 
family. HtrA2 is a serine-25 protease HtrA2 of 
485 amino acids. In humans HtrA2 is 
localized to inner mitochondrial space (IMS). 
As it has mitochondrial targeting signal. 
Mammalian has cell proptective and pro-
apoptotic role (Alnemri, 2007; Koonin and 
Aravind, 2002). Serine protease in the 
mitochondria which ensures the 
mitochondrial protein quality is ubiquitin 
independent. Activity of HtrA2 causes 
removal of accumulated and misfolded 
protein from inner mitochondrial space 
because of inhibition of UPS (Radke et al., 
2008). PINK1 has been identified as an 
important regulator for the activity of 
mitochondrial associated stress-protective 
serine protease, HtrA2 (Alnemri, 2007). P38 
dependent phosphorylation of HtrA2/Omi at 
serine 142 is mediated by PINK1. This 
phosphorylation of HtrA2/Omi being 
induced by stress boosts-up its activity. 
Finally providing a significant protection 
against Parkinsonism (Plun-Favreau et al., 
2007). The classification of HtrA2/Omi as 
PARK 13 due to presence of two mutated 
alleles of patients suffering from Parkison's 
disease (Alnemri, 2007).  PINK1 dependent 
phosphorylation of HtrA2 regulates the 
proteolytic activity of HtrA2 and makes the 
cell resistant to mitochondrial associated 
stress (Plun-Favreau et al., 2007). HtrA2 has 
no critical role in the PINK1 and Parkin 
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interactions (Tain et al., 2009). PINK1 and 
HtrA2 protect the mitochondria from stress 
within the cell to maintain the integrity of the 
cell. Without controlling the stress, cell can’t 
function properly. Genetic ablations of PINK1 
and HtrA2 are very important aspect in the 
development of Parkinsonism neuro-
degenration (Martins et al., 2004).  In patients 
suffering from Parkinson’s disease, mutations 
of PINK1 C573R and Y431H show decrease 
ability of PINK1 to phosphorylate HtrA2 in 
the postmortem brain tissue as compared 
with normal neurological control (Plun-
Favreau et al., 2007). The protease activity of 
HtrA2 protects the mitochondria from stress 
by reducing mitochondrial ROS (Krick et al., 
2008). Mutated HtrA2 is unable to perform its 
protease activity while mutated, this leads to 
the accumulation of mitochondrial unfolded 
proteins, cause defects in mitochondrial 
respiration and increases the level of ROS ; 
resulting in the ultimate neuronal death 
(Moisoi et al., 2009). Mutated HtrA2 as well 
show some phenotypic similarities with 
PINK1. Suggesting that both of them help in 
maintaining the mitochondrial integrity and 
both of them are part of stress sensing 
pathway (Alnemri, 2007). In SH-SY5Y human 
neuroblastoma cells PINK1 forms complex 
with HtrA2 but not in HtrA2 deficient cells. 
This shows that HtrA2 form complex with 
PINK1 and both are part of stress sensing 
pathway (Plun-Favreau et al., 2007). Emad, 
2007 reported that HtrA2 acts downstream to 
PINK1 but in a pathway parallel to Parkin. 
Mutated HtrA2 protease domain in mice 
shows motor neuron degeneration (mnd2) 
leads to its muscles wasting and neuro-
degenration. In another experimental HtrA2 
knocked out mouse shows progressive 
neurodegenration of dopamine neurons and 
exhibit phenotype of Parkinsonism, abnormal 
mitochondria and reduce life span as 
compared to normal mice. This highlights the 
role of HtrA2 to maintain the mitochondrial 
function and integrity of neuronal cells rather 
than its pro-apoptotic function in the neurons 
(Liu et al., 2007). Like PINK1 mutant flies, 
HtrA2 mutant flies also show reduce flight 
and climbing abilities and this is completely 
restored in HtrA2 rescued flies. 
phenotypicaly over expression of  PINK1 is 
suppressed by loss HtrA2 of but over 
expression of HtrA2 is not suppressed by  
PINK1 mutations (Alnemri, 2007). Loss of 
HtrA2 leads to only mitochondrial alterations 
in aged flies (Tain et al., 2009). Proteolytic 
HtrA2 has a conserved IAP binding domain, 
homologous to mammalian smac/DIABLO 
(Koonin and Aravind, 2002). Due to pro-
apoptotic stimulus such as UV radiations 
HtrA2 releases from mitochondria into 
cytosol causes the active cleavage of IAP 
(Yang et al., 2007). IAP (Inhibitor of apoptosis 
proteins) which further causes the activation 
of caspases leads to apoptosis (Cilenti et al., 
2004). 
 
PINK1, Parkin’s interaction with DJ-1 
Biochemical function of DJ-1 remains 
unidentified (Goldberg et al., 2005). Genetic 
ablations of DJ-1 also contribute in the 
pathogenesis of Parkinsonism, so it is also 
called PARK 7. DJ-1 is important for proper 
mitochondrial function and acts downstream 
of, or in parallel to, pink1 and maintains the 
mitochondrial integrity (Hao et al., 2010). 
Mutations in the DJ-1 gene are source of 
early-onset familial Parkinson’s disease 
(Bonifati et al., 2003; Dodson and Guo, 2007). 
In an animal model reduced function of DJ-
1A due to RNA interference leads to decrease 
phosphorylation of Akt. This shows that 
PI3K/Akt signaling becomes impaired due to 
down-regulation of DJ-1A. Similarly in 
mammals when PI3K/Akt signaling becomes 
impaired due to mutated DJ-1. This leads to 
DJ-1-associated disease pathogenesis (Yang et 
al., 2005). Parkin, PINK1, and DJ-1 formed a 
complex known as PPD complex. In an 
experiment this complex promotes 
ubiquitination of Parkin substrates like alpha-
Synphilin-1 in neuroblastoma cells and 
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human brain lysates which resulted in their 
degradation. Genetic ablation of any of these 
genes, Pink1 or Dj-1 leads to reduced 
ubiquitination of Parkin substrates as well as 
decreased degradation and increased 
accumulation of abnormally expressed Parkin 
substrates (Xiong et al., 2009). Mutant DJ-1 
mice show dopamine reuptake dysfunction 
and have increased sensitivity to the 
neurotoxin 1-methyl-4-phenyl-1,2,3,6-
tetrahydropyrindine (MPTP) (Hao et al., 
2010). In transfected cells and in Drosophila 
DJ-1 protects both cells from oxidative stress 
(Bonifati  et al., 2003; Meulener et al., 2005). 
Silencing of Dj-1 in mouse and PINK1 in 
Drosophila causes mitochondrial dysfunction 
and increased sensitivity to oxidative stress 
(Goldberg et al., 2005).  Mutually, Parkin, 
PINK1, and DJ-1 protect cells against 
oxidative stress by way of a common 
mechanism, portentous potential functional 
relations between the three proteins. These 
results propose that the Parkin/PINK1/DJ-1 
(PPD) complex plays an important role in 
degradation of denatured and regulatory 
proteins through UPS (Xiong et al., 2009). In 
SH-SY5Y neuroblastoma cells localization of 
the PPD complex is determined by 
immunostaining and cellular fractionation. 
By fractionation analysis of SH-SY5Y cells 
these proteins Parkin, PINK1, and DJ-1 are 
detected in both the mitochondrial and the 
cytosolic fractions and colocalization of 
Parkin, PINK1, and DJ-1 is largely observed 
in the cytoplasm of cultured primary human 
neurons.PPD complex is more abundant in 
the cytosolic fraction as compared to 
mitochondrial fraction and only a little 
amount of the PPD complex is present in the 
mitochondrial fraction (Xiong et al., 2009). 
PPD promotes degradation of Synphilin-1 by 
means of the ubiquitin-proteasome system. 
WT DJ-1(DJ-1WT) and pathogenic loss of 
function mutant DJ-1L166P are utilized in the 
experiment to define the promising role of 
DJ-1 in the PPD complex. The presence of DJ-
1WT upregulates the ubiquitination of Parkin 
not disregarding the fact that steady-going 
level of Parkin is not altered. Tied in findings 
were prevailed with Synphilin-1. These 
findings proposed that DJ-1WT, and not PD-
associated DJ-1A39S, is involved in 
stabilizing the level of PINK1. DJ-1 
potentially modulates PINK1 in the PPD 
complex because the cells expressing DJ-1 
result in the systematically increased balance 
level of PINK1.One of the possible role of DJ-
1 in PPD complex is to stabilize PINK1, and 
DJ-1 also assists however it is not vital for the 
action of E3 ligase complex.  Parkin, PINK1 
and DJ-1 all these three proteins therefore as 
well solely work out with the protection 
against oxidative stress (Menzies  et al., 2005; 
Moore et al., 2005). 
 
PD and signaling cascades: current insights 
TGF signaling 
It is interesting to note that transforming 
growth factor-beta (TGF-beta) is significant 
for maintenance of structural integrity of 
dopaminergic neurons. TGF-beta2 
haploinsufficiency results in defective 
neurons Andrews et al, 2006; Vawter et al, 
1996; Roussa et al, 2009. It has recently been 
explored that neurotrophic factor and 
transforming growth factor β1 are involved in 
the neuroprotection Gonzalez-Aparicio et al, 
2010. In agreement with the same assumption 
it was also noted that CD4+CD25+ regulatory 
T cells triggered the up regulation of 
neurotrophic factor and transforming growth 
factor β1 Reynolds et al, 2007. 
Wnt signaling 
Compelling evidence indicates that 
Dishevelled (DVL) interacts with and triggers 
the activation of small GTPases structurally 
similar to the LRRK2 Roc domain. It is 
obvious that LRRK2 Roc-COR domain and 
the DVL1 DEP domain are necessary for 
LRRK2-DVL1 interaction. Furthermore, co-
expression of DVL1 escalated LRRK2 steady-
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state protein levels. Outstandingly, LRRK2-
DVL1-3 associations were impaired by the 
familial PARK8 mutation Y1699C. This is 
indicative of the fact that mutations underpin 
lack of association between DVL1 and LRRK2 
and drive neurodegeneration Sancho et al, 
2009. Another interesting piece of evidence is 
that cells transfected with Wnt5a (VMN-
Wnt5a) generated 10-fold more dopaminergic 
neurons than did conventional FGF2-treated 
neurons Parish et al, 2008. On a similar note 
inhibition of negative regulators of Wnt 
signaling, glycogen synthetase kinase (GSK) 
resulted in an increment in the dopaminergic 
neurons Castelo-Branco et al, 2004 
SHH signaling 
It is important to note that Wnt1-lmx1a forms 
a novel autoregulatory loop and henceforth 
regulates dopaminergic differentiation 
concomitantly with the SHH-FoxA2 pathway 
Chung et al, 2009. It has been documented 
that expression of the transcription factor Gli1 
within neurons is neuroprotective for 
dopaminergic neurons in vivo Suwelack et al, 
2004. Contrary to this another documentation 
suggests lack of any association between 
mutations in SHH and pathogenesis of PD 
Bak et al, 2004. Another important crosstalk 
between SHH and FGF8 was dismantled and 
it was suggested that overexpression of 
nuclear receptor Nurr1 re-sensitized the cells 
to extrinsic signals of both of these ligands 
Kim et al, 2003. 
PD and ATM 
DNA damage results in activation of ATM 
that induces cell loss and apoptosis. On the 
contrary, suppression of ATM attenuates the 
ATM mediated cell loss Camins et al, 2010. It 
has been found that ATM gene product is 
required for cell survival and genomic 
stability after exposure to low labile iron 
concentrations. Keeping in view the 
safeguarding activities of ATM it is obvious 
that pharmacological manipulation of ATM 
activity might offer exciting avenues for 
rational drug design Edwin et al, 2005.  
PD and PDGF 
Platelet-derived growth factor BB (PDGF-BB) 
and Platelet-derived growth factor CC 
(PDGF-CC)  are members of the PDGF family 
and are involved in the structural integrity 
and differentiation of dopaminergic neurons 
Tang et al, 2010; Mohapel et al, 2005. 
miRNA and PD: therapeutic implications 
It has lately been found that increasing the 
level of let-7 or miR-184 hampered 
pathogenic leucine-rich repeat kinase 2 
(LRRK2) Gehrke et al, 2010. Another 
interesting piece of evidence is that reduction 
of the affinity of miR-433 to the 3' UTR up 
regulated FGF20 expression and enhanced 
expression of alpha-synuclein, which could in 
turn promote dopaminergic neurons 
degeneration. Nonetheless, the research 
group was unable to document association 
between rs12720208 and PD, or an effect of 
miR-433 variants on this disease de Mena et 
al, 2010. 
Conclusion 
It is getting increasingly essential to unravel 
negative regulators which relentlessly 
challenge integrity of neuron. A detailed 
mechanistic insight is unavoidable get a step 
closer to individualized medicine. 
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